We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Obesity, Metabolic Syndrome, and Prediabetes
Center of Excellence
Interested in receiving weekly updates about the Obesity, Metabolic Syndrome, and Prediabetes Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Chandrakant Madgaonkar
Feb 22, 2018
The current experience is that the short acting insulin analogs lispro and aspart are safe; however, long acting insulin analogs can also be added and dosage titrated to prevent hypoglycemia. Nutritional management is the cornerstone of treatment; insulin, glyburide and metformin can be used to intensify treatment. Neonatal hypoglycemia and potential fetal harm needs to be avoided.
Anica Badanjak
Feb 01, 2019
Insulin analog detemir is still insulin of choice as basal insulin in management DM in pregnancy
Rajeev Gupta
Feb 22, 2019
Isapgol husk 5gm three times a day, dissolved with a glass of water before meals, will help her in many ways, like control of in the fluctuations in blood sugar, relief in constipation etc. It is shown to reduce HbA1C by 0.5%. If she can tolerate it, it may help her.
Arati shahade
Oct 29, 2019
She requires pre pregnancy counselling. allow her weight and BSL to settle down before planned pregnancy. CGMS and insulin pump are good idea for management . Judicious dietary advise depending on post preandial variation is to be sought.
It would be ideal to lose weight either by medical or surgical management. Intra gastric balloon can be an option if we are looking at a small to modest weight loss.
Sandeep Julka
Nov 29, 2019
How about using insulin pump for her. She will soon get thw steroids for fetal lung maturation too...
bendib samir
May 02, 2020
Nutritional management +basal analog insulin+pre prandial insulin lispro or humalog with postprandial glycaemia<=120mg,no indication to oad.
Apr 19, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Anika
Anam
MD
Chandrakant Madgaonkar
Feb 22, 2018
Anica Badanjak
Feb 01, 2019
Rajeev Gupta
Feb 22, 2019
Arati shahade
Oct 29, 2019
Sandeep Julka
Nov 29, 2019
bendib samir
May 02, 2020
Apr 19, 2024
Pending Moderator approval.